EX-3.1 2 ea182870ex3-1_adialpharm.htm CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADIAL PHARMACEUTICALS, INC

Exhibit 3.1

 

 

State of Delaware

Secretary of State

Division of Corporations

Delivered 08:03 AM 08/03/2023

FILED 08:03 AM 08/03/2023

SR 20233153666 - File Number 6439279 

CERTIFICATE OF AMENDMENT
OF
 

CERTIFICATE OF INCORPORATION
OF

ADIAL PHARMACEUTICALS, INC.

 

Adial Pharmaceuticals, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify that:

 

1.The name of the Corporation is Adial Pharmaceuticals, Inc.

 

2.The Board of Directors of the Corporation has duly adopted a resolution pursuant to Section 242 of the General Corporation Law of the State of Delaware setting forth a proposed amendment to the Certificate of Incorporation of the Corporation and declaring said amendment to be advisable. The requisite stockholders of the Corporation have duly approved said proposed amendment in accordance with Section 242 of the General Corporation Law of the State of Delaware. The amendment amends the Certificate of Incorporation of the Corporation as follows:

 

3.The Certificate of Incorporation is hereby amended by adding the following new paragraph C to ARTICLE IV:

 

“C. Reverse Stock Split.

 

Effective at 11:59 p.m. Eastern Time on the day immediately following the filing of this Certificate of Amendment to the Certificate of Incorporation (the “Effective Time”) each share of the Corporation’s common stock, $0.001 par value per share (the “Old Common Stock”), either issued or outstanding or held by the Corporation as treasury stock, immediately prior to the Effective Time, will be automatically reclassified and combined (without any further act) into a smaller number of shares such that each twenty (25) shares of Old Common Stock issued and outstanding or held by the Company as treasury stock immediately prior to the Effective Time is reclassified and combined into one share of Common Stock, $0.001 par value per share, of the Corporation (the “New Common Stock”) (the “Reverse Stock Split”). Notwithstanding the immediately preceding sentence, no fractional shares shall be issued and, in lieu thereof, any person who would otherwise be entitled to a fractional share of Common Stock as a result of the reclassification and combination following the Effective Time (after taking into account all fractional shares of Common Stock otherwise issuable to such holder) shall be entitled to receive a cash payment equal to the number of shares of the common stock held by such stockholder before the Reverse Stock Split that would otherwise have been exchanged for such fractional share interest multiplied by the average closing sales price of the Common Stock as reported on the Nasdaq for the ten days preceding the Effective Time.

 

Each stock certificate that, immediately prior to the Effective Time, represented shares of Common Stock that were issued and outstanding immediately prior to the Effective Time shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of Common Stock after the Effective Time into which the shares of Common Stock formerly represented by such certificate shall have been reclassified and combined (as well as the right to receive cash in lieu of fractional shares of Common Stock after the Effective Time), provided however, that each person of record holding a certificate that represented shares of Common Stock that were issued and outstanding immediately prior to the Effective Time shall receive, upon surrender of such certificate, a new certificate evidencing and representing the number of whole shares of Common stock after the Effective Time into which the shares of Common Stock formerly represented by such certificate shall have been combined.”

 

4.The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

5.This Certificate of Amendment shall be effective as of August 4, 2023 at 11:59 p.m. Eastern Time.

 

[SIGNATURE PAGE TO CERTIFICATE OF AMENDMENT]

 

2

 

 

IN WITNESS WHEREOF, Adial Pharmaceuticals, Inc. has caused this Certificate to be duly executed by the undersigned duly authorized officer as of this 3rd day of August, 2023.

 

  ADIAL PHARMACEUTICALS, INC.
   
  By: /s/ Cary J. Claiborne            
  Name: Cary J. Claiborne
  Title: President and Chief Executive Officer

 

 

3